These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37277655)

  • 1. Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis.
    Smith MH; Gao VR; Periyakoil PK; Kochen A; DiCarlo EF; Goodman SM; Norman TM; Donlin LT; Leslie CS; Rudensky AY
    Nat Immunol; 2023 Jul; 24(7):1200-1210. PubMed ID: 37277655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis.
    Kugler M; Dellinger M; Kartnig F; Müller L; Preglej T; Heinz LX; Simader E; Göschl L; Puchner SE; Weiss S; Shaw LE; Farlik M; Weninger W; Superti-Furga G; Smolen JS; Steiner G; Aletaha D; Kiener HP; Lewis MJ; Pitzalis C; Tosevska A; Karonitsch T; Bonelli M
    Ann Rheum Dis; 2023 Sep; 82(9):1142-1152. PubMed ID: 37344156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulating peroxisome proliferator-activated receptor-gamma coactivator-1 beta alleviates the proinflammatory effect of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting extracellular signal-regulated kinase, p38 and nuclear factor-kappaB activation.
    Zhou JJ; Ma JD; Mo YQ; Zheng DH; Chen LF; Wei XN; Dai L
    Arthritis Res Ther; 2014 Oct; 16(5):472. PubMed ID: 25367151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis.
    Alsaleh G; Sparsa L; Chatelus E; Ehlinger M; Gottenberg JE; Wachsmann D; Sibilia J
    Arthritis Res Ther; 2010; 12(4):R135. PubMed ID: 20615213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pro Nerve Growth Factor and Its Receptor p75NTR Activate Inflammatory Responses in Synovial Fibroblasts: A Novel Targetable Mechanism in Arthritis.
    Farina L; Minnone G; Alivernini S; Caiello I; MacDonald L; Soligo M; Manni L; Tolusso B; Coppola S; Zara E; Conti LA; Aquilani A; Magni-Manzoni S; Kurowska-Stolarska M; Gremese E; De Benedetti F; Bracci-Laudiero L
    Front Immunol; 2022; 13():818630. PubMed ID: 35309353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming in response to pro-inflammatory cytokines is a feature of adult synovial but not dermal fibroblasts.
    Crowley T; O'Neil JD; Adams H; Thomas AM; Filer A; Buckley CD; Clark AR
    Arthritis Res Ther; 2017 Feb; 19(1):35. PubMed ID: 28187781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression.
    Angiolilli C; Grabiec AM; Ferguson BS; Ospelt C; Malvar Fernandez B; van Es IE; van Baarsen LG; Gay S; McKinsey TA; Tak PP; Baeten DL; Reedquist KA
    Ann Rheum Dis; 2016 Feb; 75(2):430-8. PubMed ID: 25452308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
    Woolley DE; Tetlow LC
    Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis.
    Lories RJ; Derese I; Ceuppens JL; Luyten FP
    Arthritis Rheum; 2003 Oct; 48(10):2807-18. PubMed ID: 14558086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.
    Lee A; Qiao Y; Grigoriev G; Chen J; Park-Min KH; Park SH; Ivashkiv LB; Kalliolias GD
    Arthritis Rheum; 2013 Apr; 65(4):928-38. PubMed ID: 23335080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.
    Ohata J; Zvaifler NJ; Nishio M; Boyle DL; Kalled SL; Carson DA; Kipps TJ
    J Immunol; 2005 Jan; 174(2):864-70. PubMed ID: 15634908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting bioenergetics prevents CD4 T cell-mediated activation of synovial fibroblasts in rheumatoid arthritis.
    Petrasca A; Phelan JJ; Ansboro S; Veale DJ; Fearon U; Fletcher JM
    Rheumatology (Oxford); 2020 Oct; 59(10):2816-2828. PubMed ID: 32047926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.
    Hou WS; Li W; Keyszer G; Weber E; Levy R; Klein MJ; Gravallese EM; Goldring SR; Brömme D
    Arthritis Rheum; 2002 Mar; 46(3):663-74. PubMed ID: 11920402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis.
    Kasperkovitz PV; Timmer TC; Smeets TJ; Verbeet NL; Tak PP; van Baarsen LG; Baltus B; Huizinga TW; Pieterman E; Fero M; Firestein GS; van der Pouw Kraan TC; Verweij CL
    Arthritis Rheum; 2005 Feb; 52(2):430-41. PubMed ID: 15692990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide decreases rheumatoid arthritis fibroblast-like synoviocyte proliferation, invasion, inflammation and presents a therapeutic effect in collagen-induced arthritis rats via inactivating lncRNA RP11-83J16.1 mediated URI1 and β-catenin signaling.
    Piao X; Zhou J; Xue L
    Int Immunopharmacol; 2021 Oct; 99():108010. PubMed ID: 34358861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory Fibroblast-Like Synoviocytes Cell Membrane Coated Nanoparticles: A Novel Targeted Therapy for Rheumatoid Arthritis.
    Liu Y; Rao P; Qian H; Shi Y; Chen S; Lan J; Mu D; Chen R; Zhang X; Deng C; Liu G; Shi G
    Adv Sci (Weinh); 2023 Feb; 10(4):e2204998. PubMed ID: 36509660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis synovial fibroblasts produce a soluble form of the interleukin-7 receptor in response to pro-inflammatory cytokines.
    Badot V; Durez P; Van den Eynde BJ; Nzeusseu-Toukap A; Houssiau FA; Lauwerys BR
    J Cell Mol Med; 2011 Nov; 15(11):2335-42. PubMed ID: 21129157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of niclosamide on inflammation and migration of fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Liang L; Huang M; Xiao Y; Zen S; Lao M; Zou Y; Shi M; Yang X; Xu H
    Inflamm Res; 2015 Apr; 64(3-4):225-33. PubMed ID: 25708600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.
    Xu L; Feng X; Tan W; Gu W; Guo D; Zhang M; Wang F
    Arthritis Res Ther; 2013 Oct; 15(5):R170. PubMed ID: 24286242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.